Alan Glicklich - Net Worth and Insider Trading
Alan Glicklich Net Worth
The estimated net worth of Alan Glicklich is at least $318,717 dollars as of 2024-09-23. Alan Glicklich is the Chief Medical Officer of Chinook Therapeutics Inc and owns about 7,891 shares of Chinook Therapeutics Inc (KDNY) stock worth over $318,717. Details can be seen in Alan Glicklich's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan Glicklich has not made any transactions after 2022-02-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alan Glicklich
Alan Glicklich Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alan Glicklich owns 2 companies in total, including Aduro Biotech Inc (ADRO) , and Chinook Therapeutics Inc (KDNY) .
Click here to see the complete history of Alan Glicklich’s form 4 insider trades.
Insider Ownership Summary of Alan Glicklich
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADRO | Aduro Biotech Inc | 2020-10-05 | Chief Medical Officer |
| KDNY | Chinook Therapeutics Inc | 2022-02-11 | Chief Medical Officer |
Alan Glicklich Latest Holdings Summary
Alan Glicklich currently owns a total of 1 stock. Alan Glicklich owns 7,891 shares of Chinook Therapeutics Inc (KDNY) as of February 11, 2022, with a value of $318,717.
Latest Holdings of Alan Glicklich
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KDNY | Chinook Therapeutics Inc | 2022-02-11 | 7,891 | 40.39 | 318,717 |
Holding Weightings of Alan Glicklich
Alan Glicklich Form 4 Trading Tracker
According to the SEC Form 4 filings, Alan Glicklich has made a total of 2 transactions in Chinook Therapeutics Inc (KDNY) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Chinook Therapeutics Inc is the sale of 2,391 shares on February 11, 2022, which brought Alan Glicklich around $30,461.
Insider Trading History of Alan Glicklich
- 1
Alan Glicklich Trading Performance
Alan Glicklich Ownership Network
Alan Glicklich Owned Company Details
What does Aduro Biotech Inc do?
Who are the key executives at Aduro Biotech Inc?
Alan Glicklich is the Chief Medical Officer of Aduro Biotech Inc. Other key executives at Aduro Biotech Inc include director & President & CEO Eric Dobmeier , 10 percent owner Versant Voyageurs I, L.p. , and 10 percent owner Versant Voyageurs I Parallel, L.p. .
Aduro Biotech Inc (ADRO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aduro Biotech Inc (ADRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aduro Biotech Inc (ADRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aduro Biotech Inc (ADRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aduro Biotech Inc Insider Transactions
Alan Glicklich Mailing Address
Above is the net worth, insider trading, and ownership report for Alan Glicklich. You might contact Alan Glicklich via mailing address: C/o Chinook Therapeutics U.s., Inc., 1600 Fairview Ave. E., Seattle Wa 98102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
